Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05504811 · ClinicalTrials.gov registry record · NA
FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease
A NA study, sponsored by Flint Rehabilitation Devices.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05504811 is a NA study that has completed, run by Flint Rehabilitation Devices. The registered enrollment target is 31 participants.
The verdict
NCT05504811, a NA study, has completed, sponsored by Flint Rehabilitation Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
This study will investigate the efficacy of a newly developed exercise device (FitMi AD) for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease. FitMi AD uses embedded sensors that can track and record the patient's direction and degree of movement while performing exercises described on a computer.
Interventions
- DEVICE FitMi AD
- OTHER Conventional exercise program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2023-09-08 |
| Est. Completion | 2025-03-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05504811
The ClinicalTrials.gov registry entry for NCT05504811 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Flint Rehabilitation Devices, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FitMi AD is the first listed.
NCT05504811 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05504811 about?
NCT05504811 is a clinical study titled "FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease". This study will investigate the efficacy of a newly developed exercise device (FitMi AD) for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease. FitMi AD uses embedded sensors that can track and record the patient's direction and degree of movement while per...
What is the current status of trial NCT05504811?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2023-09-08. Estimated completion is 2025-03-12.
What interventions are being tested in trial NCT05504811?
The interventions under investigation include: FitMi AD (DEVICE), Conventional exercise program (OTHER).
Who is sponsoring clinical trial NCT05504811?
This trial is sponsored by Flint Rehabilitation Devices, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.